Preliminary correlative analysis of clinical outcomes with PIK3CA mutation (mut) status from a phase I/Ib study of GDC-0077 in patients (pts) with hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2-mBC) Meeting Abstract
| Authors: | Jhaveri, K.; Juric, D.; Varga, A.; Turner, N.; Schmid, P.; Saura, C.; Oliveira, M.; Krop, I. E.; Kalinsky, K.; Italiano, A.; Hamilton, E.; Gambardella, V.; Cervantes, A.; Bedard, P. L.; Liu, B. P.; Chen, J. W.; Aimi, J.; Royer-Joo, S.; Schutzman, J. L.; Hutchinson, K. E. |
| Abstract Title: | Preliminary correlative analysis of clinical outcomes with PIK3CA mutation (mut) status from a phase I/Ib study of GDC-0077 in patients (pts) with hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2-mBC) |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737701005 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-PS5-12 |
| Notes: | Meeting Abstract: PS5-12 -- This symposium was held virtually due to COVID-19 -- Source: Wos |
